SCRG_03194 Antibody

What is SCRG_03194 Antibody and what does it target?

SCRG_03194 Antibody is a research-grade antibody that targets a specific protein (B3LNR8) in Saccharomyces cerevisiae (strain RM11-1a), commonly known as Baker's yeast . This antibody serves as a valuable tool for detecting and studying its target protein in various experimental applications.

Methodological approach: When initiating studies with this antibody, researchers should first validate its specificity using positive and negative controls in their specific experimental system. Western blot analysis with cell lysates from wild-type and knockout strains can provide confirmation of antibody specificity prior to application in more complex experiments.

What are the primary research applications for SCRG_03194 Antibody?

While specific application data for SCRG_03194 is limited in the literature, this antibody belongs to CUSABIO's antibody line which supports multiple research applications including ELISA, Western Blotting (WB), Immunohistochemistry/Immunocytochemistry (IHC/ICC), Immunofluorescence (IF), Immunoprecipitation (IP/Co-IP), Chromatin Immunoprecipitation (ChIP), and Flow Cytometry (FC) .

Methodological approach: Researchers should conduct preliminary validation experiments for each intended application. For example, for Western blotting, determine optimal antibody dilution (typically starting with 1:1000) and implement proper controls (including secondary antibody-only controls) to ensure signal specificity.

How should SCRG_03194 Antibody be stored and handled to maintain activity?

Based on standard practices for research antibodies:

Methodological approach:

• Store antibody at -20°C for long-term storage (aliquot to avoid freeze-thaw cycles)

• For working solutions, store at 4°C for up to one month

• Avoid repeated freeze-thaw cycles by preparing appropriately sized aliquots

• When handling, keep on ice and minimize exposure to room temperature

• Prior to use, centrifuge the vial briefly to collect solution at the bottom of the tube

What controls should be included when using SCRG_03194 Antibody in immunological experiments?

Methodological approach:

• Positive control: Wild-type Saccharomyces cerevisiae (strain RM11-1a) expressing the target protein

• Negative control: When possible, use knockout or knockdown strains lacking the target protein

• Secondary antibody-only control: To identify non-specific binding of the secondary detection system

• Isotype control: Use an irrelevant antibody of the same isotype to identify non-specific binding

• Blocking peptide control: When available, pre-incubate antibody with excess target peptide to confirm specificity

These controls help distinguish between specific signal and background, particularly important when working with yeast samples where cross-reactivity can occur.

What is the recommended protocol for using SCRG_03194 Antibody in Western blot analysis?

Methodological approach:

• Sample preparation:

  • Culture yeast cells to mid-log phase

  • Harvest cells and prepare protein extraction using glass bead lysis in appropriate buffer

  • Quantify protein concentration (BCA or Bradford assay)

• SDS-PAGE and transfer:

  • Load 20-50 μg of protein per lane

  • Separate proteins using 10-12% SDS-PAGE

  • Transfer to PVDF or nitrocellulose membrane

• Immunoblotting:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with primary SCRG_03194 Antibody (1:1000 dilution) overnight at 4°C

  • Wash 3× with TBST, 5 minutes each

  • Incubate with appropriate HRP-conjugated secondary antibody for 1 hour at room temperature

  • Wash 3× with TBST, 5 minutes each

  • Develop using ECL substrate and image

• Analysis:

  • Verify band size against expected molecular weight

  • Compare signal with positive and negative controls

How can SCRG_03194 Antibody be used in immunoprecipitation experiments?

Methodological approach:

• Cell lysate preparation:

  • Harvest yeast cells in mid-log phase

  • Lyse cells in non-denaturing lysis buffer with protease inhibitors

  • Clear lysate by centrifugation (14,000×g, 10 minutes, 4°C)

• Antibody binding:

  • Pre-clear lysate with Protein A/G beads (1 hour, 4°C)

  • Incubate 500 μg of pre-cleared lysate with 2-5 μg SCRG_03194 Antibody overnight at 4°C with gentle rotation

  • Add 30 μl of Protein A/G beads and incubate for 2-4 hours at 4°C

• Washing and elution:

  • Wash immunoprecipitates 3× with cold lysis buffer

  • Elute bound proteins with 2× SDS sample buffer at 95°C for 5 minutes

• Analysis:

  • Analyze by SDS-PAGE and Western blotting

  • Confirm successful IP using a separate antibody against the target or with mass spectrometry

How can SCRG_03194 Antibody be used in chromatin immunoprecipitation (ChIP) to study protein-DNA interactions?

Methodological approach:

• Crosslinking and chromatin preparation:

  • Crosslink yeast cells with 1% formaldehyde for 10 minutes at room temperature

  • Quench with 125 mM glycine for 5 minutes

  • Harvest cells and lyse with glass beads

  • Sonicate chromatin to achieve fragments of 200-500 bp

• Immunoprecipitation:

  • Pre-clear chromatin with Protein A/G beads

  • Incubate chromatin with 2-5 μg SCRG_03194 Antibody overnight at 4°C

  • Add Protein A/G beads and incubate for 2-4 hours at 4°C

  • Wash immunoprecipitates with increasing stringency buffers

• Reverse crosslinking and DNA purification:

  • Reverse crosslinks at 65°C overnight

  • Treat with Proteinase K and RNase A

  • Purify DNA using phenol-chloroform extraction or commercial kits

• Analysis:

  • Analyze by qPCR for specific target genes

  • Alternatively, perform ChIP-seq for genome-wide binding profile

This protocol should be optimized for the specific target protein and experimental conditions.

What approaches can be used to troubleshoot weak or non-specific signals when using SCRG_03194 Antibody?

Methodological approach for troubleshooting:

• Signal too weak:

  • Increase antibody concentration or incubation time

  • Optimize protein extraction protocol to ensure target protein preservation

  • Use enhanced chemiluminescence substrate for western blots

  • Consider signal amplification systems for IHC/IF

• Non-specific background:

  • Increase blocking time or concentration

  • Optimize antibody dilution (perform titration experiments)

  • Increase washing stringency (time, buffer composition)

  • Use more specific secondary antibodies

  • Pre-adsorb antibody with non-specific proteins

• False positive signals:

  • Validate with knockout/knockdown controls

  • Perform peptide competition assays

  • Use alternative antibodies targeting different epitopes of the same protein

• No signal despite positive controls:

  • Verify protein expression in your specific strain

  • Check buffer compatibility and sample preparation method

  • Ensure target epitope is accessible (consider native vs. denatured conditions)

How can SCRG_03194 Antibody be used in co-immunoprecipitation to study protein-protein interactions?

Methodological approach:

• Sample preparation:

  • Use mild lysis conditions to preserve protein-protein interactions

  • Include protease and phosphatase inhibitors

  • Maintain native protein conformations by avoiding harsh detergents

• Co-immunoprecipitation:

  • Pre-clear lysate with Protein A/G beads

  • Incubate with SCRG_03194 Antibody (2-5 μg) overnight at 4°C

  • Add Protein A/G beads and incubate for 2-4 hours

  • Wash with buffers that preserve protein interactions (avoid high salt)

• Analysis:

  • Elute bound proteins and analyze by SDS-PAGE

  • Perform Western blotting for suspected interaction partners

  • For unknown partners, consider mass spectrometry analysis

• Validation:

  • Confirm interactions with reverse co-IP experiments

  • Validate with orthogonal methods (e.g., proximity ligation assay)

This approach can identify novel protein interactions in Saccharomyces cerevisiae, similar to techniques used in studies like the two-way co-immunoprecipitation described in for other protein interactions.

How should researchers interpret quantitative differences in signal intensity when using SCRG_03194 Antibody across experimental conditions?

Methodological approach:

• Normalization strategies:

  • Always normalize to appropriate loading controls (e.g., GAPDH, actin)

  • For western blots, use densitometry software with background subtraction

  • For flow cytometry, normalize to isotype controls and total cell count

• Statistical analysis:

  • Perform experiments with biological replicates (minimum n=3)

  • Apply appropriate statistical tests based on data distribution

  • Report both statistical significance and effect size

• Interpretation considerations:

  • Consider whether changes reflect protein abundance or epitope accessibility

  • Account for post-translational modifications that might affect antibody binding

  • Validate findings with orthogonal techniques (e.g., mass spectrometry)

What are the best practices for comparing results from different lots of SCRG_03194 Antibody?

Methodological approach:

• Lot-to-lot validation:

  • Test each new lot alongside the previous lot

  • Include identical positive controls across experiments

  • Document lot-specific optimal dilutions and conditions

• Standardization:

  • Establish internal reference standards

  • Use quantitative controls (e.g., recombinant proteins at known concentrations)

  • Maintain consistent experimental conditions across lots

• Data normalization:

  • Express results relative to consistent controls

  • Consider using ratio-based measurements rather than absolute values

  • Document lot numbers in all experimental records and publications

This approach minimizes variability introduced by antibody lot changes, ensuring research reproducibility and continuity.

How can SCRG_03194 Antibody be used in combination with other techniques to study protein localization and dynamics?

Methodological approach:

• Subcellular fractionation with immunoblotting:

  • Separate yeast cellular compartments (cytosol, nucleus, mitochondria)

  • Perform Western blotting with SCRG_03194 Antibody on each fraction

  • Include compartment-specific markers for validation

• Immunofluorescence microscopy:

  • Fix yeast cells with formaldehyde

  • Permeabilize cell wall (enzymatic digestion) and membrane

  • Stain with SCRG_03194 Antibody followed by fluorophore-conjugated secondary antibody

  • Co-stain with organelle markers and DAPI

  • Analyze using confocal microscopy

• Live cell imaging:

  • Generate GFP-tagged version of target protein

  • Validate tag functionality with SCRG_03194 Antibody

  • Perform time-lapse imaging to study protein dynamics

• Correlative techniques:

  • Combine immunofluorescence with electron microscopy for ultrastructural localization

What are the considerations for using SCRG_03194 Antibody in studies involving post-translational modifications?

Methodological approach:

• Modification-specific analysis:

  • Use phosphatase inhibitors during sample preparation if studying phosphorylation

  • Consider separate immunoprecipitations for modified vs. unmodified forms

  • Use specific antibodies against post-translational modifications alongside SCRG_03194

• Validation approaches:

  • Treat samples with modifying or demodifying enzymes

  • Use mass spectrometry to confirm modification status of immunoprecipitated proteins

  • Compare wild-type with mutation-bearing strains (modification site mutants)

• Experimental controls:

  • Include samples with induced or inhibited modifications

  • Use modified and unmodified recombinant proteins as controls when available

The strategic combination of SCRG_03194 Antibody with modification-specific antibodies can provide insights into the regulation of the target protein in different cellular contexts.

How does the performance of SCRG_03194 Antibody compare with other methods for studying this target protein?

Methodological comparison:

• Antibody-based methods (SCRG_03194) vs. genetic tagging:

  • Advantages of SCRG_03194: Detects endogenous protein without genetic modification

  • Advantages of tagging: Often higher specificity and compatibility with standardized protocols

  • Consider using both approaches for validation

• Comparison with mass spectrometry-based approaches:

  • Antibody advantages: Higher sensitivity for low-abundance proteins, better for targeted analysis

  • MS advantages: Unbiased detection, identification of novel modifications

  • Complementary use: Immunoprecipitation with SCRG_03194 followed by MS analysis

• Comparison with genetic approaches:

  • Antibody advantages: Studies native protein in various conditions

  • Genetic approaches: Clearer phenotypic outcomes, functional insights

  • Integrated approach: Correlate SCRG_03194 detection with phenotypic changes in genetic variants

This comparative approach ensures robust findings through methodological triangulation.

What are the analytical considerations when using SCRG_03194 Antibody in different strains of Saccharomyces cerevisiae?

Methodological approach:

• Strain validation:

  • Confirm target protein sequence conservation across strains

  • Perform epitope mapping or sequence alignment to identify potential variations

  • Validate antibody reactivity in each strain before extensive experiments

• Strain-specific protocol adjustments:

  • Optimize lysis conditions based on cell wall differences between strains

  • Adjust antibody concentration based on target protein expression levels

  • Consider strain-specific interfering factors

• Comparative analysis framework:

  • Include reference strains in all experiments

  • Normalize results to account for strain-specific baseline differences

  • Document strain-specific protocol modifications

This methodological framework enables reliable cross-strain comparisons while accounting for biological variability.